Relation between serum IL-4, IL-13 and IFN-γ levels and recurrence of wheezing episodes in infants with acute bronchiolitis

Pediatric Allergy and Immunology

Volumn 19, Issue 7, 2008, Pages 648-651

  Uzuner, Nevin ^a   Gurcu, Ozlem ^a   Olmez, Duygu ^a   Babayigit, Arzu ^a   Islekel, Huray ^a   Karaman, Ozkan ^a   Tezcan, Dilek ^a  

^a DOKUZ EYLUL UNIVERSITY   (Turkey)

Author keywords

interferon; Acute bronchiolitis; Interleukin 13; Interleukin 4; Recurrent wheezing

Indexed keywords

GAMMA INTERFERON; IMMUNOLOGIC FACTOR; INTERLEUKIN 13; INTERLEUKIN 4;

ALLERGY; ANAMNESIS; ARTICLE; ATOPY; BLOOD LEVEL; BRONCHIOLITIS; CLINICAL STUDY; CORRELATION ANALYSIS; ENVIRONMENTAL FACTOR; FAMILY HISTORY; FEMALE; HUMAN; INFANT; INFECTION; LABORATORY TEST; LOWER RESPIRATORY TRACT INFECTION; MAJOR CLINICAL STUDY; MALE; OBSTRUCTIVE AIRWAY DISEASE; PRESCHOOL CHILD; PRIORITY JOURNAL; RECURRENCE RISK; RECURRENT DISEASE; RISK FACTOR; SEX DIFFERENCE; VENOUS BLOOD; WHEEZING;

ACUTE DISEASE; BRONCHIOLITIS; CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT; INTERFERON-GAMMA; INTERLEUKIN-13; INTERLEUKIN-4; MALE; RECURRENCE; RESPIRATORY SOUNDS;

EID: 54249088496     PISSN: 09056157     EISSN: 13993038     Source Type: Journal    
DOI: 10.1111/j.1399-3038.2007.00694.x     Document Type: Article

References (23)

1. Pifferi M, Ragazzo V, Caramella D, Baldini G. Eosinophil cationic protein in infants with respiratory syncytial virus bronchiolitis: predictive value for subsequent development of persistent wheezing. Pediatr Pulmonol 2001 : 31 : 419 24.
2. Henry RL, Hodges IG, Milner AD, Stokes GM. Respiratory problems 2 years after acute bronchiolitis in infancy. Arch Dis Child 1983 : 58 : 713 6.
3. Korppi M, Reijonen T, Poysa L, Juntunen-Backman K. A 2- to 3-year outcome after bronchiolitis. Am J Dis Child 1993 : 147 : 628 31.
4. Reijonen T, Korppi M, Kuikka L, Remes K. Anti-inflammatory therapy reduces wheezing after bronchiolitis. Arch Pediatr Adolesc Med 1996 : 150 : 512 7.
5. Kuikka L, Reijonen T, Remes K, Korppi M. Bronchial asthma after early childhood wheezing: a follow-up until 4.5-6 years of age. Acta Paediatr 1994 : 83 : 744 8.
6. Sly PD, Hibbert ME. Childhood asthma following hospitalization with acute viral bronchiolitis in infancy. Pediatr Pulmonol 1989 : 7 : 153 8.
7. Chung KF, Barnes PJ. Cytokines in asthma. Thorax 1999 : 54 : 825 57.
8. Mosmann TR, Sad S. The expanding universe of T-cell subsets: Th1, Th2 and more. Immunol Today 1996 : 17 : 138 46.
9. Cokugras H, Karadag B, Dagli E, Tanac R, Tanir G. Solunum Sistemi İnfeksiyonlari Calisma Grubu, Pediatrik Akciger Hastaliklari Calisma Grubu, Toraks Dernegi Akut Bronsiolit Tani ve Tedavi Rehberi. Toraks Dergisi Ek 2002 : 3 : 29 35.
10. Reijonen TM, Korppi M, Kuikka L, et al. Serum eosinophil cationic protein as a predictor of wheezing after bronchiolitis. Pediatr Pulmonol 1997 : 23 : 397 403.
11. Bont L, Heijnen CJ, Kavelaars A, et al. Monocyte IL-10 production during respiratory syncytial virus bronchiolitis is associated with recurrent wheezing in a one-year follow-up study. Am J Respir Crit Care Med 2000 : 161 : 1518 23.
12. Chung HL, Kim SG. RANTES may be predictive of later recurrent wheezing after respiratory syncytial virus bronchiolitis in infants. Ann Allergy Asthma Immunol 2002 : 88 : 463 7.
13. Ehlenfield DR, Cameron K, Welliver RC. Eosinophilia at the time of respiratory syncytial virus bronchiolitis predicts childhood reactive airway disease. Pediatrics 2000 : 105 : 79 83.
14. Rusconi R, Patria MF, Cislaghi GU, Sideri S, Gagliardi L. Total serum IgE and outcome in infants with recurrent wheezing. Arch Dis Child 2001 : 85 : 23 5.
15. Ly NP, Rifas-Shiman SL, Litonjua AA, et al. Cord blood cytokines and acute lower respiratory illnesses in the first year of life. Pediatrics 2007 : 119 : e171 8.
16. Koopman LP, Savelkoul H, van Benten IJ, Gerritsen J, Brunekreef B, Neijens HJ. Increased serum IL-10/IL-12 ratio in wheezing infants. Pediatr Allergy Immunol 2003 : 14 : 112 9.
17. Dakhama A, Park JW, Taube C, et al. The enhancement or prevention of airway hyperresponsiveness during reinfection with respiratory syncytial virus is critically dependent on the age at first infection and IL-13 production. J Immunol 2005 : 175 : 1876 83.
18. You D, Becnel D, Wang K, et al. Exposure of neonates to respiratory syncytial virus is critical in determining subsequent airway response in adults. Respir Res 2006 : 7 : 107.
19. Chung HL, Park HJ, Kim SY, Kim SG. Age-related difference in immune responses to respiratory syncytial virus infection in young children. Pediatr Allergy Immunol 2007 : 18 : 94 9.
20. Stein RT, Sherrill D, Morgan WJ, et al. Respiratory syncytial virus in early life and risk of wheeze and allergy by age 13 years. Lancet 1999 : 354 : 541 5.
21. Robinson DS, Hamid Q, Ying S, et al. Predominant TH2-like bronchoalveolar T-lymphocyte population in atopic asthma. N Engl J Med 1992 : 326 : 298 304.
22. Sigurs N. Clinical perspectives on the association between respiratory syncytial virus and reactive airway disease. Respir Res 2002 : 3 : S8 14.
23. Simoes EA. Respiratory syncytial virus infection. Lancet 1999 : 354 : 847 52.